Cargando…
IL-33 targeting attenuates intestinal mucositis and enhances effective tumour chemotherapy in mice
Intestinal damage and severe diarrhea are serious side effects of cancer chemotherapy and constrain the usage of most such therapies. Here we show that IL-33 mediates the severe intestinal mucositis in mice treated with Irinotecan (CPT-11), a commonly used cancer chemotherapeutic agent. Systemic CPT...
Autores principales: | Guabiraba, R, Besnard, A G, Menezes, G B, Secher, T, Jabir, M S, Amaral, S S, Braun, H, Lima-Junior, R C P, Ribeiro, R A, Cunha, F Q, Graham, G J, Teixeira, M M, Beyaert, R, Liew, F Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077764/ https://www.ncbi.nlm.nih.gov/pubmed/24424522 http://dx.doi.org/10.1038/mi.2013.124 |
Ejemplares similares
-
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
por: Li, Dong, et al.
Publicado: (2014) -
IL-33-Mediated Protection against Experimental Cerebral Malaria Is Linked to Induction of Type 2 Innate Lymphoid Cells, M2 Macrophages and Regulatory T Cells
por: Besnard, Anne-Gaelle, et al.
Publicado: (2015) -
The Role of IL-33 in Gut Mucosal Inflammation
por: Pastorelli, Luca, et al.
Publicado: (2013) -
IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut()
por: Sattler, Susanne, et al.
Publicado: (2014) -
The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages
por: Yang, Yunlong, et al.
Publicado: (2016)